Richard Jenkins

Adjunct Assistant Professor of Economics at Booth School of Business

Schools

  • Booth School of Business

Links

Biography

Booth School of Business

Richard Jenkins is an Adjunct Assistant Professor of Economics at the University of Chicago, where he teaches 33301 (Management, Labor and Industrial Relations) and 33303 (Managing in the Regulated Environment).

Jenkins has 25 years of management experience under regulated environments, ranging from organized labor/unions under the Department of Labor, to biomedical development under the Food and Drug Administration and airlines under the Federal Aviation Administration. He has founded one National Institutes of Health SBIR-financed company and serves on the board of a second.

Airline employers include Southwest Airlines where he serves as a Chief Pilot and JetBlue Airways, where he was employee number 177. He has started two biomedical companies (Electrogram and Ann Arbor Biomedical) and later worked in private equity/venture capital at Arch Development Partners, concentrating on portfolio drug and FDA-regulated companies.

His research interests include the application of the Booth quantitative framework to union membership sentiment measurement through the use of statistical sampling and surveying, and the development/use of innovative methods to populate medical device research trials.

Jenkins headed the strategic arm of the Southwest Airlines Pilot Association, a powerful transportation union. During his five-year tenure, he assisted in the facilitation of the merger between two public companies (LUV/AAI) and the resultant workforce seniority integration which was completed without requiring union-forced arbitration. He testified before the Department of Justice Anti-trust division regarding the projected competitive effects of the Southwest Airlines/AirTran Airways merger.

He worked at the venture capital firm Arch Development Partners, concentrating on the commercialization of university research and portfolio company challenges and opportunities under the Food and Drug Administration and the National Institutes of Health biomedical research Innovation funding.

Jenkins received his MBA with honors from the University of Chicago, where his team placed second in the Polsky New Venture Challenge (Varna Research, a medical device testing company). He served on the Booth admissions committee for five years.

In 1992 as a biomedical entrepreneur, Jenkins founded Electrogram, a biomedical data firm which serves cardiac device developers. He co-founded Ann Arbor Biomedical, a cardiac device test developer that received a National Institute of Health (NIH) innovation phase I grant and he currently serves as an investor and board member of Cardioalarm, which also received phase I and phase II NIH grants to develop a subcutaneous arrhythmia monitor.

Jenkins is an active investor in startup ventures and commercial real estate. He holds a patent on the design and testing of implantable cardioverter devices.

 

Read about executive education

Other experts

Joseph Vavra

Joseph Vavra, Associate Professor of Economics, studies macroeconomics and monetary economics, the influence of housing on the macroeconomy and the effects of regional business cycles on aggregate activity. In his recent research he argues that monetary policy is less effective during volatile re...

Judith Apsley

Biography Judith Apsley received her BA in Electrical Sciences from Cambridge University in 1986, and her PhD from the University of Surrey in 1996. She started her career as a Technologist Apprentice at Westland Helicopters (1982-87), then as an Electrical Engineer in the Machines and Drives Dep...

Ujwal Kayande

Ujwal Kayande is the Associate Dean (Academic) and Professor of Marketing at Melbourne Business School. He is also Founding Director of the Centre for Business Analytics. He teaches marketing strategy and analytics on the MBA, Master of Business Analytics and Executive Education programs. Ujwal i...

Looking for an expert?

Contact us and we'll find the best option for you.

Something went wrong. We're trying to fix this error.